Cat.NO.:A243088 Purity:95%
Product Details of [ 100-32-3 ]
| CAS No. : | 100-32-3 |
| Formula : |
C12H8N2O4S2 |
| M.W : |
308.33
|
| SMILES Code : | O=[N+](C1=CC=C(SSC2=CC=C([N+]([O-])=O)C=C2)C=C1)[O-] |
| MDL No. : | MFCD00003573 |
| InChI Key : | KWGZRLZJBLEVFZ-UHFFFAOYSA-N |
| Pubchem ID : | 7496 |
Safety of [ 100-32-3 ]
| GHS Pictogram: | ![]() |
| Signal Word: | Warning |
| Hazard Statements: | H302+H312+H332-H351 |
| Precautionary Statements: | P201-P202-P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P308+P313-P405-P501 |
Computational Chemistry of [ 100-32-3 ] Show Less
Physicochemical Properties
| Num. heavy atoms | 20 |
| Num. arom. heavy atoms | 12 |
| Fraction Csp3 | 0.0 |
| Num. rotatable bonds | 5 |
| Num. H-bond acceptors | 4.0 |
| Num. H-bond donors | 0.0 |
| Molar Refractivity | 82.24 |
| TPSA ?
Topological Polar Surface Area: Calculated from |
142.24 Ų |
Lipophilicity
| Log Po/w (iLOGP)?
iLOGP: in-house physics-based method implemented from |
2.14 |
| Log Po/w (XLOGP3)?
XLOGP3: Atomistic and knowledge-based method calculated by |
3.68 |
| Log Po/w (WLOGP)?
WLOGP: Atomistic method implemented from |
4.3 |
| Log Po/w (MLOGP)?
MLOGP: Topological method implemented from |
2.8 |
| Log Po/w (SILICOS-IT)?
SILICOS-IT: Hybrid fragmental/topological method calculated by |
-0.68 |
| Consensus Log Po/w?
Consensus Log Po/w: Average of all five predictions |
2.45 |
Water Solubility
| Log S (ESOL):?
ESOL: Topological method implemented from |
-4.18 |
| Solubility | 0.0202 mg/ml ; 0.0000655 mol/l |
| Class?
Solubility class: Log S scale |
Moderately soluble |
| Log S (Ali)?
Ali: Topological method implemented from |
-6.36 |
| Solubility | 0.000136 mg/ml ; 0.00000044 mol/l |
| Class?
Solubility class: Log S scale |
Poorly soluble |
| Log S (SILICOS-IT)?
SILICOS-IT: Fragmental method calculated by |
-3.88 |
| Solubility | 0.0406 mg/ml ; 0.000132 mol/l |
| Class?
Solubility class: Log S scale |
Soluble |
Pharmacokinetics
| GI absorption?
Gatrointestinal absorption: according to the white of the BOILED-Egg |
Low |
| BBB permeant?
BBB permeation: according to the yolk of the BOILED-Egg |
No |
| P-gp substrate?
P-glycoprotein substrate: SVM model built on 1033 molecules (training set) |
No |
| CYP1A2 inhibitor?
Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) |
Yes |
| CYP2C19 inhibitor?
Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) |
Yes |
| CYP2C9 inhibitor?
Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) |
Yes |
| CYP2D6 inhibitor?
Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) |
Yes |
| CYP3A4 inhibitor?
Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) |
Yes |
| Log Kp (skin permeation)?
Skin permeation: QSPR model implemented from |
-5.57 cm/s |
Druglikeness
| Lipinski?
Lipinski (Pfizer) filter: implemented from |
0.0 |
| Ghose?
Ghose filter: implemented from |
None |
| Veber?
Veber (GSK) filter: implemented from |
1.0 |
| Egan?
Egan (Pharmacia) filter: implemented from |
1.0 |
| Muegge?
Muegge (Bayer) filter: implemented from |
0.0 |
| Bioavailability Score?
Abbott Bioavailability Score: Probability of F > 10% in rat |
0.55 |
Medicinal Chemistry
| PAINS?
Pan Assay Interference Structures: implemented from |
0.0 alert |
| Brenk?
Structural Alert: implemented from |
3.0 alert: heavy_metal |
| Leadlikeness?
Leadlikeness: implemented from |
No; 1 violation:MW<1.0 |
| Synthetic accessibility?
Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) |
2.62 |
Application In Synthesis of [ 100-32-3 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
- Downstream synthetic route of [ 100-32-3 ]








Reviews
There are no reviews yet.